We estimate that the CEO and President of Natera, Inc. ($NTRA), Steven Chapman, received a compensation of $14,957,319 in 2025. This is an increase of 12.87% from an estimated $13,032,674 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 23, 2026. Note that parsing errors may occur.
You can track $NTRA on Quiver Quantitative's $NTRA stock dashboard.
$NTRA Stock Insider Trading Activity
$NTRA Stock insiders have traded $NTRA stock on the open market 215 times in the past 6 months. Of those trades, 0 have been purchases and 215 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 25 sales selling 354,055 shares for an estimated $76,609,331.
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 26 sales selling 240,000 shares for an estimated $46,295,059.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 23 sales selling 80,224 shares for an estimated $18,780,207.
- ROELOF BOTHA has made 0 purchases and 11 sales selling 75,000 shares for an estimated $17,708,935.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 30 sales selling 53,114 shares for an estimated $12,002,414.
- HERM ROSENMAN has made 0 purchases and 4 sales selling 48,419 shares for an estimated $11,011,477.
- JONATHAN SHEENA has made 0 purchases and 57 sales selling 45,447 shares for an estimated $9,873,427.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 18 sales selling 43,428 shares for an estimated $9,469,617.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 9 sales selling 25,867 shares for an estimated $5,971,026.
- ROY D. BAYNES has made 0 purchases and 8 sales selling 12,780 shares for an estimated $2,809,688.
- ROWAN E CHAPMAN has made 0 purchases and 3 sales selling 4,488 shares for an estimated $1,084,737.
- GAIL BOXER MARCUS sold 122 shares for an estimated $24,242
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Stock Government Contracts
We have seen $463,800 of award payments to $NTRA over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TUMOR WHOLE EXOME SEQUENCING (WES) AND PERIPHERAL BLOOD CTDNA TEST TESTING (SINGLE ASSAY) SERVICES AND WES ...: $154,100
- GENETIC TESTING: $79,200
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$NTRA Stock Hedge Fund Activity
We have seen 405 institutional investors add shares of $NTRA Stock stock to their portfolio, and 330 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COATUE MANAGEMENT LLC added 2,463,008 shares (+1446.1%) to their portfolio in Q4 2025, for an estimated $564,250,502
- WELLINGTON MANAGEMENT GROUP LLP added 2,420,263 shares (+94.7%) to their portfolio in Q4 2025, for an estimated $554,458,050
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,307,662 shares (-75.7%) from their portfolio in Q4 2025, for an estimated $528,662,287
- JPMORGAN CHASE & CO added 1,225,420 shares (+10.5%) to their portfolio in Q4 2025, for an estimated $280,731,467
- RTW INVESTMENTS, LP removed 1,093,645 shares (-42.2%) from their portfolio in Q4 2025, for an estimated $250,543,133
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,075,426 shares (-9.0%) from their portfolio in Q4 2025, for an estimated $246,369,342
- CITADEL ADVISORS LLC removed 786,720 shares (-87.7%) from their portfolio in Q4 2025, for an estimated $180,229,684
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTRA Stock Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 04/14/2026
- Canaccord Genuity issued a "Buy" rating on 12/22/2025
- BTIG issued a "Buy" rating on 12/05/2025
- JP Morgan issued a "Overweight" rating on 11/25/2025
- UBS issued a "Buy" rating on 11/18/2025
- Stephens & Co. issued a "Overweight" rating on 11/13/2025
- Piper Sandler issued a "Overweight" rating on 11/11/2025
To track analyst ratings and price targets for $NTRA Stock, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Stock Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 13 analysts offer price targets for $NTRA in the last 6 months, with a median target of $260.0.
Here are some recent targets:
- Tejas Savant from Morgan Stanley set a target price of $250.0 on 03/03/2026
- Catherine Ramsey from Baird set a target price of $257.0 on 02/27/2026
- Daniel Markowitz from Evercore ISI Group set a target price of $260.0 on 02/27/2026
- Brandon Couillard from Wells Fargo set a target price of $215.0 on 02/27/2026
- Patrick Donnelly from Citigroup set a target price of $300.0 on 01/07/2026
- Subbu Nambi from Guggenheim set a target price of $270.0 on 01/05/2026
- Kyle Mikson from Canaccord Genuity set a target price of $285.0 on 12/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
